We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hybrid Imaging Technology Shows Potential in Identifying Hard-to-Detect Ovarian Cancer

By HospiMedica International staff writers
Posted on 20 Sep 2011
By combining three previously distinct imaging modalities into one new device, a team of researchers has proposed a new way to diagnose early-stage ovarian cancer in high-risk women through minimally invasive surgery. More...
The new technique may be better than the current standard procedure of preemptively removing the ovaries.

Ovarian cancer has a low survival rate because a lack of effective screening techniques typically means the disease remains hidden until the later stages. Now researchers from the University of Connecticut (Storrs, USA) and the University of Southern California (USC; Los Angeles, USA) have drawn on the unique advantages of multiple imaging approaches to evaluate a new way of spotting early-on the tissue irregularities that are hallmarks of cancer.

For their diagnostic device, the researchers combined the contrast provided by photoacoustic imaging, the high-resolution subsurface imaging provided by optical coherence tomography (OCT), and the deeper tissue imaging provided by pulse-echo ultrasound. They assessed their device, described by the team in the September 2011 issue of the Optical Society’s (OSA) open-access journal Biomedical Optics Express, by imaging both pig and human ovarian tissue, and accurately identified malignant tumors that were later validated by staining the tissue and examining it under a microscope. These early tests were performed on tissue that had been surgically removed, but the diameter of the device--at only 5 mm--is small enough that it could potentially be inserted through a small slit to image tissue in live patients.

Related Links:

University of Connecticut
University of Southern California




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.